JENIFER MALLOW: Open Payments
NPI 1538689336 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 48 payments from 14 companies in 2025. Trend: 2023 $559 · 2024 $356 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 12 | $229 |
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| Novartis Pharmaceuticals Corporation | 7 | $177 |
| Daiichi Sankyo Inc. | 4 | $95 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| Genentech USA, Inc. | 3 | $45 |
| ABBVIE INC. | 1 | $30 |
| Incyte Corporation | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
Products named: Orserdu, Enhertu, KISQALI, KEYTRUDA, LIBTAYO, Itovebi, IMJUDO, SCEMBLIX.
Industry payments across TX — which companies pay providers there.
